Asset
VS-4718
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02215629 | phase1 | withdrawn | — | 2016-09-01 | Verastem, Inc. | Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia |
| NCT01849744 | phase1 | terminated | 2013-06-01 | 2017-04-01 | Verastem, Inc. | Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies |
FDA applications (0)
This company has no applications containing this asset.